Author(s):
Nishith M. C., M. P. Venkatesh
Email(s):
mcnishith@gmail.com , venkateshmpv@jssuni.edu.in
DOI:
10.5958/0974-360X.2019.01069.2 
Address:
Nishith M. C.1, M. P. Venkatesh*2
1Ph.D. Scholar, Regulatory Affairs Group, Dept. of Pharmaceutics, JSS College of Pharmacy,
JSS Academy of Higher Education and Research, Mysuru-570015, Karnataka, India.
2Assistant Professor, Regulatory Affairs Group, Dept. of Pharmaceutics, JSS College of Pharmacy,
JSS Academy of Higher Education and Research, Mysuru-570015, Karnataka, India
*Corresponding Author
Published In:
Volume - 12,
Issue - 12,
Year - 2019
ABSTRACT:
Herbal drugs as well as the traditional medicines are widely used and are a part of primary healthcare among world population. The demand of herbal drugs isalso seen increased in developed nations due to its beneficial side effects. As the use of herbal drugs increases worldwide, the possibility of side effects and adverse effects are also becomes more common, which necessitate well structured regulatory control over the globe. But the fact is that the legislative classification and regulatory control of herbals differ among countries and no harmonization exists in regulations. Assurance of the safety, efficacy and quality of herbal drugs remains a key issue in industrialized and developing nations. This review illustrates on how the herbal drugs are defined and to compare the different perceptions of herbal drugs regulations in Russia and India.
Cite this article:
Nishith M. C., M. P. Venkatesh. Herbal Drug Regulatory Landscape: Key Comparison between Russia and India. Research J. Pharm. and Tech. 2019; 12(12): 6153-6156. doi: 10.5958/0974-360X.2019.01069.2
Cite(Electronic):
Nishith M. C., M. P. Venkatesh. Herbal Drug Regulatory Landscape: Key Comparison between Russia and India. Research J. Pharm. and Tech. 2019; 12(12): 6153-6156. doi: 10.5958/0974-360X.2019.01069.2 Available on: https://rjptonline.org/AbstractView.aspx?PID=2019-12-12-92